Literature DB >> 7058780

Predicting coronary heart disease in siblings--a multivariate assessment: the Framingham Heart Study.

C B Snowden, P M McNamara, R J Garrison, M Feinleib, W B Kannel, F H Epstein.   

Abstract

The incidence of clinically recognized coronary heart disease and its relation to risk factors have been studied for 596 sibships in the Framingham Heart Study cohort. Only the 186 pairs of brothers were considered in the multivariate analysis, since the rate of coronary heart disease in women is low. Multiple logistic regression was performed by using endpoints of coronary heart disease as the dependent variable for the younger brother of the pair. Age, Metropolitan relative weight, systolic blood pressure, total cholesterol, cigarette smoking and endpoints of coronary heart disease for the older brother represent the independent variables. The incidence of myocardial infarction in the older brother is significantly related to myocardial infarction experience of the younger brother, even after the strong effects of total cholesterol, systolic blood pressure and cigarette smoking were controlled. These findings suggest that family history of myocardial infarction may be an important independent predictor of myocardial infarction, and suggest that familial aggregation for coronary heart disease may result from predisposition to disease, possibly genetic, that is not reflected in the measured levels of total cholesterol, systolic blood pressure or cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058780     DOI: 10.1093/oxfordjournals.aje.a113293

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

Review 1.  Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.

Authors:  P J Goldschmidt-Clermont; C M Roos; G E Cooke
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

2.  Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.

Authors:  France Gagnon; Gail P Jarvik; Arno G Motulsky; Samir S Deeb; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2003-08-29       Impact factor: 4.132

3.  Is a family history of coronary heart disease an independent coronary risk factor?

Authors:  R M Conroy; R Mulcahy; N Hickey; L Daly
Journal:  Br Heart J       Date:  1985-04

4.  Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors.

Authors:  Anna Konopka; Małgorzata Szperl; Walerian Piotrowski; Marta Roszczynko; Janina Stępińska
Journal:  Mol Diagn Ther       Date:  2011-06-01       Impact factor: 4.074

5.  Coronary disease and risk factors in close relatives of Utah women with early coronary death.

Authors:  S C Hunt; K Blickenstaff; P N Hopkins; R R Williams
Journal:  West J Med       Date:  1986-09

6.  Sibling history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly: the Cardiovascular Health Study.

Authors:  N David Yanez; Gregory L Burke; Teri Manolio; Julius M Gardin; Joseph Polak
Journal:  Ann Epidemiol       Date:  2009-12       Impact factor: 3.797

7.  Family history in "low risk" men with coronary heart disease.

Authors:  R F Heller; M C Kelson
Journal:  J Epidemiol Community Health       Date:  1983-03       Impact factor: 3.710

8.  Reliability of reported family history of myocardial infarction.

Authors:  F Kee; L Tiret; J Y Robo; V Nicaud; E McCrum; A Evans; F Cambien
Journal:  BMJ       Date:  1993-12-11

9.  Impact of risk factors for non-fatal acute myocardial infarction.

Authors:  Andreia Oliveira; Henrique Barros; Ana Azevedo; Joana Bastos; Carla Lopes
Journal:  Eur J Epidemiol       Date:  2009-06-04       Impact factor: 8.082

10.  First degree family history of diabetes and risk factors for cardiovascular disease in non-diabetic subjects in the National Telephone Company: a metabolic survey.

Authors:  P Micossi; G Gallus; P Valsania; P Garancini; G Radaelli; G Pozza
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.